Stock TSVT 2SEVENTY BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News 2seventy bio, Inc.

Equities

TSVT

US9013841070

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.29 USD +0.47% Intraday chart for 2seventy bio, Inc. -7.54% +0.47%
Apr. 19 US FDA mandates label updates on CAR-T cancer therapies RE
Apr. 05 Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
US FDA mandates label updates on CAR-T cancer therapies
RE
FDA Approves BMS And J&J CAR-T Cell Therapies For The Earlier Treatment Of Multiple Myeloma
AQ
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio's Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma after Two Prior Lines of Therapy
AQ
Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication
MT
Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma
DJ
Bristol Myers: FDA approves Abecma in multiple myeloma
CF
US FDA allows expanded use of Bristol Myers' cell therapy for blood cancer
RE
U.S. FDA allows expanded use of Bristol Myers' cell therapy
RE
U.S. Fda Approves Bristol Myers Squibb and 2Seventy Bio?S Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
CI
2seventy bio : Corporate Presentation April 2024
PU
2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron
BU
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc..
CI
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc. for $15 million.
CI
Bristol Myers Squibb Gets EU OK for Cancer Treatment
DJ
Engine Capital Nominates Candidates to the Board of 2seventy bio
CI
2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors
BU
2seventy bio, Inc. Announces Board Appointments
CI
Thinking about buying stock in Solidion Technology, Nuvei, 2Seventy Bio, Aeye, or DHC Acquisition?
PR
Top Premarket Gainers
MT
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb's and 2seventy bio's Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TSVT Stock
  4. News 2seventy bio, Inc.